# fix: unblock observation review after session approval and integrate evidence drafts

An approved session could still contain pending observations, but every observation decision returned `409 Approved session is immutable`. This stranded the human-review queue and prevented documentation consolidation. Session-text approval and observation-level review are now independent: existing pending observations can be approved, corrected or rejected once, without rewriting the approved session's text, extraction, status or timestamps.

## Changes

- Remove only the session-status blocker in observation review. Retain patient linkage, same-organization reviewer checks, pending-only conditional updates, original source/text/domain preservation and transactional audit insertion. Re-review, session reprocessing, session re-approval and adding observations to approved sessions remain blocked.
- Integrate the existing Sprint 9A review-integrity/audit-loading fixes and reviewed preview/consolidated-draft components from source `be05bf9` into the dashboard codebase. No branch or PR was merged. The dashboard implementation is the parent dependency, not part of the focused fix diff.
- Register the read-only documentation endpoint, mount both existing documentation panels in the Session workspace, and refresh their eligibility after human decisions and session changes. Preserve domain-only and text-only corrections. Clear preview loading on deselection and avoid claiming a manually registered observation came from AI.
- Bind Compose's host publication to `127.0.0.1:8000:8000`. Keep the container's internal listen address and narrow development CORS allowlist intact. Document a private, authenticated demo gateway that denies public API mutations; CORS is explicitly not treated as authentication.
- Add integrated API/component/browser regression coverage. No new migrations, database schema changes, AMD inference implementation changes, clinical approval automation or signed reports.

## Validation and evidence

- Full backend suite: **85 passed**, with the existing Starlette/httpx TestClient deprecation warning.
- Frontend: **26 tests passed** across dashboard, review/audit and documentation integration suites.
- TypeScript/Vite production build: **passed**.
- `docker compose config --quiet`: **passed**; observed local listeners were `127.0.0.1:8000` and `127.0.0.1:5173`.
- Standard Chromium dashboard smoke: **passed**, including evidence/audit drill-down and no page overflow at 390/768/1440px.
- New Chromium integration smoke: **passed** on a fresh persisted synthetic fixture. A domain-only correction in an already approved session created exactly one event, left the entire session response unchanged, refreshed the preview and consolidated draft, and updated Operations/Governance to 13 reviewed observations / 13 audit events. No browser runtime exceptions.
- The workflow regression matrix covers approve/correct/reject across draft/pending/approved sessions. Before the fix, exactly the three approved-session decisions failed with the contradictory 409. Tests retain original evidence and audit history, verify no second review is allowed, preserve all session immutability checks, and ensure cross-organization/unlinked reviews remain blocked.
- Existing AMD tests still enforce synthetic acknowledgment, exact source evidence, pending outputs, no automatic session approval and rollback on failed extraction. All test mutations were limited to temporary or explicitly isolated demo databases; existing application records were not migrated or edited.

## Manual validation

Source branch: `fix/approval-review-integration`. PR target: `feat/competition-dashboards`. Parent dashboard commit: `17580b2`; integrated reviewed documentation/review source: `be05bf9`. The parent branch must be reviewed separately before eventual integration into main.

1. From `backend`, create a **new** isolated database: `.venv/bin/python -m scripts.seed_dashboard_demo --database data/audit-demo.db`. The seeder refuses existing/default files. Never use existing synthetic records for the mutating integration smoke.
2. In a server shell with `ELO_DATABASE_URL` unset, run `ELO_DB_PATH="$PWD/data/audit-demo.db" ELO_INFERENCE_MODE=mock .venv/bin/python -m uvicorn app.main:app --host 127.0.0.1 --port 8000`.
3. From `frontend`, run `npm install --package-lock=false`, then `VITE_API_URL=http://127.0.0.1:8000 npm run dev -- --host 127.0.0.1 --port 5173 --strictPort`.
4. Functional Intelligence → an **approved** session → Inspect evidence → Open session workspace. Copy the synthetic reviewer ID from an existing decision in that session. Confirm consolidation is blocked while one observation is pending. Select the reviewer, correct only that observation's functional domain, and confirm the decision.
5. Verify the session's existing approved text/timestamp/status remain unchanged; observation audit history has the new decision and original source. The preview shows zero pending and three accepted observations, and the consolidated panel shows **SYNTHETIC DRAFT — NOT A CLINICAL RECORD**. Rejected observations remain excluded. Return to dashboards to see the updated counts/trace.
6. Automatic repetition with a fresh fixture and running services: from `frontend`, run `CHROMIUM_PATH=/usr/bin/chromium npm run test:browser` followed by `CHROMIUM_PATH=/usr/bin/chromium npm run test:integration`. The second command intentionally records one synthetic correction and must not be rerun on the modified fixture. If using a Playwright-installed browser, omit `CHROMIUM_PATH`.
7. Local test commands: backend `PYTHONPATH=. .venv/bin/python -m pytest -q`; frontend `npm test` and `npm run build`.

## Exposure recommendations and limits

See [DEMO_API_EXPOSURE.md](https://github.com/Ralado51/elo-functional-intelligence/blob/fix/approval-review-integration/docs/DEMO_API_EXPOSURE.md) for the reviewed attack surface, loopback/Compose behavior and an illustrative authenticated read-only gateway configuration.

Do not publish port 8000 or unauthenticated POST endpoints. A future approved audience deployment needs HTTPS, audience authentication, private backend networking/firewall rules and gateway-enforced denial of mutations; operator writes belong on a separate private authenticated route/tunnel. The gateway recommendation was not deployed or externally security-tested. Local CORS tests deliberately demonstrate that direct-client writes still work without authentication; CORS is not the protection boundary.

This remains a synthetic-only, unauthenticated research prototype, without verified clinician identities or tenant authorization. AMD credentials remain server-side and inference telemetry remains unavailable unless persisted. Existing migration prerequisites still apply; no production/PostgreSQL runtime validation or real-patient processing is claimed. Consolidation is a read-only deterministic draft, not a diagnosis, progress inference, signature or finalized clinical record. Nothing was merged, deployed or submitted.
